Sheets Smith Wealth Management Regeneron Pharmaceuticals, Inc. Transaction History
Sheets Smith Wealth Management
- $789 Million
- Q1 2025
A detailed history of Sheets Smith Wealth Management transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Sheets Smith Wealth Management holds 1,226 shares of REGN stock, worth $717,810. This represents 0.1% of its overall portfolio holdings.
Number of Shares
1,226
Previous 1,160
5.69%
Holding current value
$717,810
Previous $826,000
5.93%
% of portfolio
0.1%
Previous 0.1%
Shares
9 transactions
Others Institutions Holding REGN
# of Institutions
1,490Shares Held
87.1MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$5.44 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.95 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.13 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.83 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$2.77 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $62.8B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...